Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
Curdlan A bioactive mammalian disaccharide associated with autoimmunity activates STI... 2019 Nat Commun. Fermaintt C.S. et al. DOI: 10.1038/s41467-019-10319-5
BX795 A bioactive mammalian disaccharide associated with autoimmunity activates STI... 2019 Nat Commun. Fermaintt C.S. et al. DOI: 10.1038/s41467-019-10319-5
Zymosan A bioactive mammalian disaccharide associated with autoimmunity activates STI... 2019 Nat Commun. Fermaintt C.S. et al. DOI: 10.1038/s41467-019-10319-5
Ruxolitinib A bioactive mammalian disaccharide associated with autoimmunity activates STI... 2019 Nat Commun. Fermaintt C.S. et al. DOI: 10.1038/s41467-019-10319-5
Furfurman A bioactive mammalian disaccharide associated with autoimmunity activates STI... 2019 Nat Commun. Fermaintt C.S. et al. DOI: 10.1038/s41467-019-10319-5
R848 VacciGrade™ STING agonists activate latently infected cells and enhance SIV-specific resp... 2019 Sci Rep. Yamamoto T. et al. DOI: 10.1038/s41598-019-42253-3
c-di-AMP VacciGrade™ STING agonists activate latently infected cells and enhance SIV-specific resp... 2019 Sci Rep. Yamamoto T. et al. DOI: 10.1038/s41598-019-42253-3
Pam3CSK4 VacciGrade™ STING agonists activate latently infected cells and enhance SIV-specific resp... 2019 Sci Rep. Yamamoto T. et al. DOI: 10.1038/s41598-019-42253-3
LPS-EB VacciGrade™ STING agonists activate latently infected cells and enhance SIV-specific resp... 2019 Sci Rep. Yamamoto T. et al. DOI: 10.1038/s41598-019-42253-3
Loxoribine STING agonists activate latently infected cells and enhance SIV-specific resp... 2019 Sci Rep. Yamamoto T. et al. DOI: 10.1038/s41598-019-42253-3
ODN 2006 VacciGrade™ STING agonists activate latently infected cells and enhance SIV-specific resp... 2019 Sci Rep. Yamamoto T. et al. DOI: 10.1038/s41598-019-42253-3
TL8-506 STING agonists activate latently infected cells and enhance SIV-specific resp... 2019 Sci Rep. Yamamoto T. et al. DOI: 10.1038/s41598-019-42253-3
2'3'-cGAMP VacciGrade™ STING agonists activate latently infected cells and enhance SIV-specific resp... 2019 Sci Rep. Yamamoto T. et al. DOI: 10.1038/s41598-019-42253-3
Flagellin FliC VacciGrade™ STING agonists activate latently infected cells and enhance SIV-specific resp... 2019 Sci Rep. Yamamoto T. et al. DOI: 10.1038/s41598-019-42253-3
Poly(I:C) (HMW) VacciGrade™ STING agonists activate latently infected cells and enhance SIV-specific resp... 2019 Sci Rep. Yamamoto T. et al. DOI: 10.1038/s41598-019-42253-3
ODN 2395 - TLR9 ligand Repository corticotropin injection reverses critical elements of the TLR9/B c... 2019 Clin Immunol. Olsen N.J. et al. DOI: 10.1016/j.clim.2019.02.009
Tri-DAP lnc TINCR induced by NOD1 mediates inflammatory response in 3T3-L1 adipocytes. 2019 Gene Fang Y.X. et al. DOI: 10.1016/j.gene.2019.02.047
Human NOD2 Reporter HEK293 Cells (NF-κB) Antibody neutralization of microbiota-derived circulating peptidoglycan dampe... 2019 Nat Microbiol. Huang Z. et al. DOI: 10.1038/s41564-019-0381-1
HKSA Dysfunctional high-density lipoprotein activates toll-like receptors via seru... 2019 Sci Rep. Schuchardt M. et al. DOI: 10.1038/s41598-019-39846-3
OxPAPC Dysfunctional high-density lipoprotein activates toll-like receptors via seru... 2019 Sci Rep. Schuchardt M. et al. DOI: 10.1038/s41598-019-39846-3

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty